Extends ICON's leadership in commercialisation and market access
services and brings new scientific communications capabilities
DUBLIN--(BUSINESS WIRE)--
ICON
plc (NASDAQ:ICLR), a global provider of drug development
solutions and services to the pharmaceutical, biotechnology and medical
device industries, today announced that it has completed the acquisition
of MediMedia Pharma Solutions. The acquisition brings ICON new
scientific communications capabilities which together with ICON's
existing Commercialisation and Outcomes practices, creates the
industry's leading integrated market access solution.
Commenting on the completion of the acquisition, ICON Chief Executive
Officer, Ciaran Murray, said: "Helping customers establish and
communicate the value of their products has become increasingly
important as payers look for evidence linking efficacy, value and price.
MediMedia deepens the expertise and capabilities of our market-leading
commercialisation and outcomes group and brings outstanding scientific
and medical communications capabilities. We are delighted to welcome
them to the ICON team."
About ICON plc
ICON plc is a global provider of drug development solutions and services
to the pharmaceutical, biotechnology and medical device industries. The
company specialises in the strategic development, management and
analysis of programs that support clinical development - from compound
selection to Phase I-IV clinical studies. With headquarters in Dublin,
Ireland, ICON currently, operates from 83 locations in 38 countries and
has approximately 10,600 employees.
Further information is available at www.iconplc.com.
About MediMedia Pharma Solutions
MediaMedia Pharma Solutions is a combination of MediMedia Managed
Markets and Complete HealthCare Communications.
MediMedia Managed Markets is a leading provider of strategic
payer-validated market access solutions for the biopharmaceutical and
medical device industries. Their comprehensive approach includes
scientific analysis and assessment, research and insights, strategic
development, tactical development, and program execution. Complete
HealthCare Communications is one of the largest medical communication
agencies and is a pioneer in publication services, providing strategic
consulting, software solutions, and scientific communications to medical
affairs teams for life sciences firms globally.
Further information is available at http://www.medimediamanagedmarkets.com
and www.thechcgroup.com.
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and industry
conditions. These statements are not guarantees of future performance or
actual results, and actual results, developments and business decisions
may differ from those stated in this press release. The forward-looking
statements are subject to future events, risks, uncertainties and other
factors that could cause actual results to differ materially from those
projected in the statements, including, but not limited to, the ability
to enter into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the integration of
new business mergers and acquisitions, as well as economic and global
market conditions and other risks and uncertainties detailed from time
to time in SEC reports filed by ICON, all of which are difficult to
predict and some of which are beyond our control. For these reasons, you
should not place undue reliance on these forward-looking statements when
making investment decisions. The word "expected" and variations of such
words and similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they are
made and we do not undertake any obligation to update publicly any
forward-looking statement, either as a result of new information, future
events or otherwise. More information about the risks and uncertainties
relating to these forward-looking statements may be found in SEC reports
filed by ICON, including its Form 20-F, F-1, S-8 and F-3, which are
available on the SEC's website at http://www.sec.gov.
ICON/ICLR-F
ICON Media Contact
Weber Shandwick
Rebecca Power, +44
(0) 207 067 0866
RPower@webershandwick.com
Source: ICON plc
News Provided by Acquire Media
